The event will showcase how technology is a playing a critical role in Ashland’s growth strategy and highlight the company’s portfolio of scalable technologies, according to Ashland.
31.10.2022 - WILMINGTON, Del., Oct. 31, 2022 (GLOBE NEWSWIRE) - Ashland Inc. (NYSE: ASH) today announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research Office of New Drugs has accepted Ashland Viatel bioresorbable .
Wilmington, Del., Aug. 30, 2022 (GLOBE NEWSWIRE) Ashland has announced a strategically significant expansion of its Viatel bioresorbable polymer manufacturing and research and development site at the